Interest Expense in USD of TG THERAPEUTICS, INC. from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Tg Therapeutics, Inc. quarterly/annual Interest Expense history and change rate from Q2 2010 to Q1 2024.
  • Tg Therapeutics, Inc. Interest Expense for the quarter ending 31 Mar 2024 was $2.29M, a 19.6% decline year-over-year.
  • Tg Therapeutics, Inc. Interest Expense for the twelve months ending 31 Mar 2024 was $12.1M, a 16.3% increase year-over-year.
  • Tg Therapeutics, Inc. annual Interest Expense for 2023 was $12.6M, a 23.8% increase from 2022.
  • Tg Therapeutics, Inc. annual Interest Expense for 2022 was $10.2M, a 80.8% increase from 2021.
  • Tg Therapeutics, Inc. annual Interest Expense for 2021 was $5.64M, a 10.9% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

TG THERAPEUTICS, INC. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $12.1M $2.29M -$556K -19.6% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2024
Q4 2023 $12.6M $2.43M -$431K -15.1% 01 Oct 2023 31 Dec 2023 10-K 29 Feb 2024
Q3 2023 $13M $3.71M +$2.07M +125% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2023
Q2 2023 $11M $3.63M +$610K +20.2% 01 Apr 2023 30 Jun 2023 10-Q 04 Aug 2023
Q1 2023 $10.4M $2.84M +$180K +6.76% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024
Q4 2022 $10.2M $2.86M +$1.78M +165% 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 $8.41M $1.65M +$610K +58.8% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023
Q2 2022 $7.8M $3.02M +$1.39M +85.9% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $6.4M $2.66M +$766K +40.4% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023
Q4 2021 $5.64M $1.08M -$211K -16.4% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024
Q3 2021 $5.85M $1.04M -$572K -35.5% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $6.42M $1.62M -$605K -27.2% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $7.03M $1.9M +$697K +58% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q4 2020 $6.33M $1.29M -$609K -32.1% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023
Q3 2020 $6.94M $1.61M +$73K +4.75% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 $6.87M $2.23M +$1.15M +107% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 $5.71M $1.2M +$427K +55.2% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021
Q4 2019 $5.29M $1.9M 01 Oct 2019 31 Dec 2019 10-K 01 Mar 2022
Q3 2019 $1.54M +$1.32M +595% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $1.08M 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $774K 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q3 2018 $221K 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q3 2016 $917K $212K -$35K -14.2% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $952K $221K -$25.8K -10.5% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2016
Q1 2016 $977K $242K +$4.75K +2% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $973K $242K +$7.24K +3.08% 01 Oct 2015 31 Dec 2015 10-K 15 Mar 2016
Q3 2015 $965K $247K +$11.7K +5% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 $954K $247K +$11.7K +5% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 $942K $238K +$11.3K +5% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 $931K $235K -$6.09K -2.53% 01 Oct 2014 31 Dec 2014 10-K 15 Mar 2016
Q3 2014 $937K $235K -$5.74K -2.39% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $943K $235K -$5.23K -2.18% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 $948K $226K -$5.13K -2.22% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 $953K $241K +$12K +5.23% 01 Oct 2013 31 Dec 2013 10-K 15 Mar 2016
Q3 2013 $941K $241K +$11.9K +5.23% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 $929K $240K +$11.9K +5.22% 01 Apr 2013 30 Jun 2013 10-Q 24 Jul 2014
Q1 2013 $917K $231K +$11.3K +5.14% 01 Jan 2013 31 Mar 2013 10-Q 14 May 2014
Q4 2012 $906K $229K 01 Oct 2012 31 Dec 2012 10-K 07 Mar 2014
Q3 2012 $229K +$229K 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 $228K +$228K 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013
Q1 2012 $220K 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013
Q3 2011 $0 +$350K 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 $0 -$351K -100% 01 Apr 2011 30 Jun 2011 10-Q/A 07 Sep 2012
Q3 2010 -$350K 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 $351K 01 Apr 2010 30 Jun 2010 10-Q/A 14 Sep 2011

TG THERAPEUTICS, INC. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.6M +$2.42M +23.8% 01 Jan 2023 31 Dec 2023 10-K 29 Feb 2024
2022 $10.2M +$4.55M +80.8% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024
2021 $5.64M -$691K -10.9% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024
2020 $6.33M +$1.04M +19.7% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
2019 $5.29M +$4.41M +503% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022
2018 $877K +$32K +3.79% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021
2017 $845K 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020
2015 $973K +$42K +4.52% 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2016
2014 $931K -$22.2K -2.33% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2016
2013 $953K +$47.1K +5.21% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016
2012 $906K +$899K +12662% 01 Jan 2012 31 Dec 2012 10-K 07 Mar 2014
2011 $7.1K 01 Jan 2011 31 Dec 2011 10-K 21 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.